Form 4: Alignment Healthcare CFO Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Alignment Healthcare's Chief Financial Officer, James M. Head, reported a sale of 11,100 common shares to cover tax withholding obligations upon the vesting of restricted stock units.
Summary
- James M. Head, Chief Financial Officer of Alignment Healthcare, Inc., reported a transaction on April 7, 2026.
- The transaction involved the sale of 11,100 shares of common stock.
- The sale was executed at a price of $21.08 per share.
- These shares were sold to cover tax withholding obligations related to the vesting of restricted stock units.
- This transaction is not considered a discretionary trade by the reporting person.
- Following this transaction, Mr. Head beneficially owns 173,495 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; the sale is for tax purposes and not indicative of a change in the executive's confidence in the company.
Negatives
- A significant number of shares (11,100) were sold, which could be perceived negatively by the market, although it was for tax withholding purposes.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it solely reports a past transaction.
Management Comments
- "This transaction does not represent a discretionary trade by the reporting person."
Industry Context
StockSavvy.ai notes that insider sales for tax withholding are common events, particularly following the vesting of equity awards. While the sale itself reduces an insider's direct holdings, the reason provided suggests it's a procedural event rather than a reflection of negative sentiment towards the company's prospects.
Stakeholder Impact
- Shareholders: The sale reduces the number of shares held by a key executive, which could be a minor point of observation, but the stated reason mitigates significant concern.
- Employees: The transaction relates to the vesting of restricted stock units, a common employee incentive, and the tax withholding process is standard.
Key Dates
| Date | Description |
|---|---|
| 04/07/2026 | Transaction Date |
| 04/08/2026 | Signature Date |
Keywords
Form 4, SEC Filing, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Alignment Healthcare, ALHC, James M. Head, Chief Financial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.